2006
DOI: 10.1080/02652030600557163
|View full text |Cite
|
Sign up to set email alerts
|

Validation and application of a robust yeast estrogen bioassay for the screening of estrogenic activity in animal feed

Abstract: len. Validation and application of a robust yeast estrogen bioassay for the screening of estrogenic activity in animal feed. Food Additives and Contaminants, 2006, 23 (06) . All of these blank and low estrogen spiked feed samples fulfilled the CCα and CCβ criterions, meaning that all 20 blank feed samples gave a signal below the determined decision limit CCα and were thus classified as compliant and at least 19 out of the 20 spiked samples gave a signal above this CCα (β=5%) and were thus classified as suspec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0

Year Published

2006
2006
2021
2021

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 45 publications
(24 citation statements)
references
References 17 publications
(12 reference statements)
1
23
0
Order By: Relevance
“…Similarly, the E2 equivalence (E2 EQ) of samples was generated based on the E2 dose-response curve. The EC 50 values of E2 dose-response curve were 1 nM which was in line with those reported previously (Bovee et al 2005(Bovee et al , 2006Simons et al 2011). The LOD is 0.1 ng E2 EQ g −1 dw.…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Similarly, the E2 equivalence (E2 EQ) of samples was generated based on the E2 dose-response curve. The EC 50 values of E2 dose-response curve were 1 nM which was in line with those reported previously (Bovee et al 2005(Bovee et al , 2006Simons et al 2011). The LOD is 0.1 ng E2 EQ g −1 dw.…”
Section: Discussionsupporting
confidence: 92%
“…AhR agonistic potentials were determined by the microethoxyresorufin-O-deethylase (EROD) bioassay based on exposure of H4IIE rat hepatoma cells (Schwirzer et al 1999). The presence of ER (ant)agonists were determined by the application of a yeast estrogen bioassay expressing a green fluorescent reporter protein upon exposure to estrogens (Bovee et al 2004(Bovee et al , 2005(Bovee et al , 2006.…”
Section: Introductionmentioning
confidence: 99%
“…According to the labels, each capsule of supplement A contained 50 mg DHEA and 10 mg vitamin C in a base of rice flour, and each capsule of supplement B contained 500 mg Tribulus terrestris, 100 mg 4-androstenedione, 100 mg DHEA, 100 mg lysine and 15 mg zinc amine acid chelate. A 100-mg aliquot of each capsule was extracted according to a method described by Bovee et al [14]. In summary, sample aliquots were mixed with 4 ml methanol and 4 ml sodium acetate buffer (0.25 M, pH 4.8), sonicated for 10 min and mixed for 15 min in a head over head apparatus.…”
Section: Extraction Of Supplement Samplesmentioning
confidence: 99%
“…The latter are relatively easy to use and very robust, making them suitable for screening of samples from practice without complex sample cleanup procedures. In addition, yeast cells lack endogenous receptors and thus lack the potential cross talk from other receptor types [14]. As a result the signals obtained in the yeast androgen bioassay may be associated only with the androgenic properties of the compound or sample extract tested.…”
Section: Introductionmentioning
confidence: 99%
“…A capsule of the supplement was opened and 100 mg of the powder was extracted as described previously for feed (Bovee et al 2006). The tablet was powdered and treated in the same way.…”
Section: Yeast Estrogen and Androgen Bioassaysmentioning
confidence: 99%